Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16763664rdf:typepubmed:Citationlld:pubmed
pubmed-article:16763664lifeskim:mentionsumls-concept:C0017296lld:lifeskim
pubmed-article:16763664lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:16763664lifeskim:mentionsumls-concept:C0205373lld:lifeskim
pubmed-article:16763664pubmed:issue21lld:pubmed
pubmed-article:16763664pubmed:dateCreated2006-10-17lld:pubmed
pubmed-article:16763664pubmed:abstractTextWe recently reported a novel coupling strategy involving salicylhydroxamic acid and phenyl(di)boronic acid molecules to attach the CNGRC peptide to PEI/DNA for CD13 targeting in tumors. Here, we doubly coupled Simian Virus (SV) 40 peptide-(nuclear localization signal)) and oligonucleotide-based (DNA nuclear targeting signal) nuclear signals to the same vector using peptide nucleic acid chemistry. This vector, CNGRC/PEG/PEI/DNA-betagal/NLS/DNTS, was predominantly localized in the cell nucleus, yielding about 200-fold higher betagal gene expression in vitro, more than 20-fold increase in tumor-specific gene delivery, and a robust betagal gene expression as demonstrated in stained tumor sections. For gene therapy purposes, we further engineered a similar targeting polyplex, CNGRC/PEG/PEI/DNA-p53/NLS/DNTS, with EBV-based episomal vector for sustained p53 gene expression. A distribution of vector DNA and apoptosis in p53-containing tumors was observed, yielding a significant tumor regression and 95% animal survival after 60 days. This multicomponent vector also co-targeted tumor and tumor-associated endothelial cells but not normal cells, and had more efficient therapeutic index than each vector administered as a single modality. The use of an efficient coupling strategy without compromising the vector's integrity for DNA condensation and endosomal escape; nuclear import; tumor-specific and persistent p53 gene expression clearly provides a basis for developing a single combinatorial approach for non-viral gene therapy.lld:pubmed
pubmed-article:16763664pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16763664pubmed:languageenglld:pubmed
pubmed-article:16763664pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16763664pubmed:citationSubsetIMlld:pubmed
pubmed-article:16763664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16763664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16763664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16763664pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16763664pubmed:statusMEDLINElld:pubmed
pubmed-article:16763664pubmed:monthNovlld:pubmed
pubmed-article:16763664pubmed:issn0969-7128lld:pubmed
pubmed-article:16763664pubmed:authorpubmed-author:CristianoR...lld:pubmed
pubmed-article:16763664pubmed:authorpubmed-author:MoffattSSlld:pubmed
pubmed-article:16763664pubmed:authorpubmed-author:WiehleSSlld:pubmed
pubmed-article:16763664pubmed:issnTypePrintlld:pubmed
pubmed-article:16763664pubmed:volume13lld:pubmed
pubmed-article:16763664pubmed:ownerNLMlld:pubmed
pubmed-article:16763664pubmed:authorsCompleteYlld:pubmed
pubmed-article:16763664pubmed:pagination1512-23lld:pubmed
pubmed-article:16763664pubmed:dateRevised2007-12-3lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:meshHeadingpubmed-meshheading:16763664...lld:pubmed
pubmed-article:16763664pubmed:year2006lld:pubmed
pubmed-article:16763664pubmed:articleTitleA multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy.lld:pubmed
pubmed-article:16763664pubmed:affiliationDepartment of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. stanley-moffatt@excite.comlld:pubmed
pubmed-article:16763664pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16763664pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16763664lld:pubmed